Staff Accountant, LevitasBio
$98-110k
Salary dependent on location + Equity
Office located in Menlo Park, CA
Advancing science with levitation technology
Open for applications
Advancing science with levitation technology
21-100 employees
Open for applications
$98-110k
Salary dependent on location + Equity
Office located in Menlo Park, CA
21-100 employees
Company mission
To advance science and human health by providing researchers with a new and powerful method of cellular analysis.
Jump to section
Company mission
To advance science and human health by providing researchers with a new and powerful method of cellular analysis.
Our take
LevitasBio is a biotechnology company dedicated to advancing human health by developing a platform for cellular analysis. Its magnetic levitation technology detects, quantifies, separates, and tests cells. The solution can be used in therapy, diagnostics, and research areas.
With Levitas, technology researchers can speed up their workflow to separate cells in minutes instead of hours. This offers new opportunities for discovery in oncology, bacteriology and immunology research. The company has also turned its attentions to developing next generation sample processing and characterization protocols, to fight the bottleneck caused by the numerous pre-processing steps needed to be able to analyze complex biological samples.
The company has raised significant funding towards expanding its portfolio and applications, with the ultimate goal of accelerating its commercial success. With its novel, next-gen products, and applications in various high-profile research projects, LevitasBio has positioned itself to lead cell-sample analysis into the future.
Freddie
Company Specialist at Welcome to the Jungle
Funding (last 2 of 3 rounds)
Nov 2022
$35m
SERIES C
Jan 2021
$18m
SERIES B
Total funding: $61m
Leadership
Utkan Demirci, Ph.D
(Co-Founder)Utkan has worked at Stanford University since 2017 as a Professor. Previously worked at Harvard Medical School for 6 years, holding various positions such as Assistant Professor and Associate Professor of Medicine. Co-founded DxNow and Koek Biotechnology.
Gozde Durmus, Ph.D
(Co-Founder)Earned a PhD in Biomedical Engineering from Brown University. Worked for 7 years at Stanford University, first as Postdoctoral Research Fellow for 5 years and then as Assistant Professor for 2 years.
Lars Steinmetz, Ph.D
(Co-Founder)Lars has worked at Stanford University School of Medicine since 2013, currently as a Co-Director of the Genome Technology Center, a Dieter Schwarz Foundation Endowed Professor of Genetics, and as a Chair of the Department of Genetic. They've also been at EMBL for 22 years, currently as an Associate Group Leader.
Martin Pieprzyk
(CEO)Prior to joining LevitasBio in 2017, they were an EVP of Sales and Marketing at Xcell Biosciences and Head of Sales and Marketing at Cellular Research. They also spent over 11 years at Fluidigm Corporation, in various roles, including Senior Product Manager and Research Associate to Senior Channel Manager and Marketing.
Geoff Facer
(CTO)Geoff initially joined LevitasBio as a VP of Engineering in 2017, becoming CTO in 2023. Previously a Director of Product Development at Becton Dickinson Genomics and Cellular Research.